Top compounds associated with response to SEC14L1


Feature Type Standardized
Nominal ANOVA
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.057 0.09
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.063 0.09
mRNA AZD0530 CTRPv2 pan-cancer AAC 0.063 0.09
mRNA MLN4924 CTRPv2 pan-cancer AAC -0.059 0.09
mRNA prima-1 CTRPv2 pan-cancer AAC 0.054 0.09
mRNA AZD7762 GDSC1000 pan-cancer AAC -0.057 0.09
mRNA StemRegenin 1 CTRPv2 pan-cancer AAC 0.06 0.09
mRNA ifosfamide CTRPv2 pan-cancer AAC -0.091 0.09
mRNA GSK429286A GDSC1000 pan-cancer AAC -0.056 0.09
mRNA phenformin GDSC1000 pan-cancer AAC -0.053 0.09
Download CSV